Free Trial
OTCMKTS:EMBI

Emerald Bioscience (EMBI) Stock Price, News & Analysis

Emerald Bioscience logo

About Emerald Bioscience Stock (OTCMKTS:EMBI)

Key Stats

Today's Range
N/A
50-Day Range
$0.09
$12.81
52-Week Range
N/A
Volume
6.96 million shs
Average Volume
14.24 million shs
Market Capitalization
$24.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Emerald Bioscience, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of cannabinoid-based therapeutics for unmet medical needs worldwide. The company's lead product candidate is NB1111, which is in preclinical trials for the treatment of glaucoma. It is also developing NB2222, a product candidate in preclinical trials for use in the treatment of various eye diseases, including uveitis, dry eye syndrome, macular degeneration, and diabetic retinopathy; and NB3111, a cannabinoid cocktail in testing for use as an anti-infective agent against various strains of antibiotic resistant bacteria, including methicillin-resistant Staphylococcus aureus. The company was formerly known as Nemus Bioscience, Inc. and changed its name to Emerald Bioscience, Inc. in March 2019. Emerald Bioscience, Inc. was founded in 2012 and is based in San Diego, California.

Receive EMBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Emerald Bioscience and its competitors with MarketBeat's FREE daily newsletter.

EMBI Stock News Headlines

PIMCO Emerging Markets Bond Instl
We recommended Palantir in 2021, now we’re recommending this...
My research indicates there is only one investment that can meet AI's unprecedented demand for energy.
Sprint Bioscience AB SPRINT
Daré Bioscience, Inc. (DARE)
See More Headlines

EMBI Stock Analysis - Frequently Asked Questions

Shares of EMBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Emerald Bioscience investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Gold Resource (GORO), Meta Platforms (META), Processa Pharmaceuticals (PCSA), Akero Therapeutics (AKRO) and CymaBay Therapeutics (CBAY).

Industry, Sector and Symbol

Sector
Medical
Industry
N/A
Sub-Industry
N/A
Current Symbol
OTCMKTS:EMBI
CIK
N/A
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Net Income
$1.05 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$24.13 million
Optionable
Not Optionable
Beta
0.43
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (OTCMKTS:EMBI) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners